nightkalalu Posted April 29, 2020 Report Posted April 29, 2020 The Food and Drug Administration has been in “sustained and ongoing” discussions with Gilead Sciences to make antiviral drug remdesivir available to Covid-19 patients “as quickly as possible, as appropriate,” the agency said Wednesday. Earlier in the day, White House health advisor Dr. Anthony Fauci said data from a coronavirus drug trial testing Gilead’s drug showed “quite good news” and sets a new standard of care for Covid-19 patients. Speaking to reporters from the White House, Fauci said he was told data from the trial showed a “clear-cut positive effect in diminishing time to recover.” The New York Times reported that the FDA plans to announce as early as Wednesday an emergency use authorization for remdesivir. FDA spokesman Michael Felberbaum told CNBC, “As part of the FDA’s commitment to expediting the development and availability of potential COVID-19 treatments, the agency has been engaged in sustained and ongoing discussions with Gilead Sciences regarding making remdesivir available to patients as quickly as possible, as appropriate.” Quote
JambaKrantu Posted April 29, 2020 Report Posted April 29, 2020 Way to go.. Hopefully it won't become another HydroxyChloroquine.. Quote
nightkalalu Posted April 29, 2020 Author Report Posted April 29, 2020 13 minutes ago, JambaKrantu said: Way to go.. Hopefully it won't become another HydroxyChloroquine.. 🤞 Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.